Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.
If any industry is bound for eternally growing demand it's cybersecurity, and right now ZS is best in class.
Our latest analysis and trading strategy on NVCR.
NVDA has weakened despite great fundamental numbers.
Here's what the the charts are saying now for the tech company.
Let's check out the PLUG charts as traders react to the latest EPS numbers.
BBY is probably evolving about as quickly and as correctly as a national big box retailer can.
Here's how to play BCO stock.
The Fed Chair threaded the needle better than Joe Montana down by six with a minute to go on any given Sunday.
As one who is long HD, I am thinking big things for the spring.
Shares of the mammoth retailer have been punished of late, but the bigger picture painted by its weekly chart shows the stock still in an uptrend.
Cryptos and cash are both headed for a real fight. For their own existence.
I want you to think about how quickly the long end of the U.S. Treasury curve is moving.
Valero Energy's dividend has not been cut, despite hard times. There is the possibility for outsized returns from a quicker than anticipated bounce back in demand, but clear risk remains.
This firm is performing well and is built to last. I just want to see if Wall Street thinks the shares are expensive here.
There's a lot to look at on the chart, so I will go through it slowly to see if you see what I see.
Let's check the charts of WMT.
While bitcoin may be getting a lot of speculative attention and dollars, the world has more history with gold and silver and base metals.
The funny thing about flat lines is that the move at the end is usually explosive, but could go either way.
This weakness following earnings probably has further to go.
Yet the stock is lower on Wednesday and the reason behind the selloff is plain to see.
3 options strategies offering very nice returns in HTLD.
After earnings, it seems money likes to bail on these stocks.
I do want to give new CEO Karen Lynch a chance. Nothing against Larry Merlo but I always thought that this stock was undervalued.
Continue to hold longs from our previous recommendation.
Disney is going to be one of the great reopening plays as economic activity normalizes.
Exelixis and Ultragenyx Pharmaceutical are cash rich mid-caps that don't look overbought.
Traders long MAT from late October can continue to hold those positions but raise sell stops.
The firm said that the global shortage of semiconductor chips could/will damage 2021 earnings.
The Russell 2000 has now soared 16% year to date, nearly twice the Nasdaq Composite's 8.5% move.